SARS-CoV-2

Mandi : Maharashtra, Tamil Nadu, Gujarat, Rajasthan, Karnataka, Delhi, Uttar Pradesh and Andhra Pradesh are the hotspots for the Covid-19 pandemic in India, according to a study released by the Indian Institute of Technology (IIT) Mandi on…

New York : Covid infection, even if mild, can trigger an immune response that lasts longer than the initial infection and recovery, according to a new study.The study by scientists at the Cedars-Sinai Medical Center, Los Angeles, showed…

New Delhi : India's overall Omicron tally increased to 2,630 after 495 fresh cases were recorded in the last 24 hours, with Maharashtra and Delhi continuing to be the worst-hit, the Union Health Ministry said.Of the total, 995 people have…

Washington : Data from several countries on the Omicron severity show that even though the variant is highly transmissible, it causes less disease than the previously Delta strain which was much more lethal, according to the US' top…

New Delhi : The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted "in principle" approval to Bharat Biotech to conduct "Phase III superiority study and Phase III booster dose study" trials…

Geneva : Amid reports that Omicron has symptoms akin to a common cold, the World Health Organisation (WHO) on Wednesday warned that it is not a common cold and should not be taken lightly.The four most common symptoms of the Omicron variant…

New Delhi : With 243 new cases of highly transmissible Covid variant Omicron detected in the last 24 hours, India's Omicron tally on Wednesday rose to 2,135 cases. Of these, 828 people have recovered from the new strain so far.Maharashtra…

New Delhi : Amid a large spike in Covid cases, the Centre on Tuesday directed the states and UTs to develop Covid care centres in hotel rooms and other similar accommodations to be linked with dedicated Covid hospitals for the care of mild…

New Delhi : Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection.Amid rising cases of new Covid variant Omicron in the country, an expert panel of the Central…

Sydney : Researchers have found that T cells - one of the body's key defences against Covid-19, can mount an effective immune response against Omicron, if antibodies fail to do that.T cells, generated both by vaccinations and Covid-19…